Literature DB >> 27017136

How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Habib Rahbar1, Elizabeth S McDonald2, Janie M Lee3, Savannah C Partridge1, Christoph I Lee4.   

Abstract

Radiologists, as administrators and interpreters of screening mammography, are considered by some to be major contributors to the potential harms of screening, including overdiagnosis and overtreatment. In this article, we outline current efforts within the breast imaging community toward mitigating screening harms, including the widespread adoption of tomosynthesis and potentially adjusting screening frequency and thresholds for image-guided breast biopsy. However, the emerging field of breast radiomics may offer the greatest promise for reducing overdiagnosis by identifying imaging-based biomarkers strongly associated with tumor biology, and therefore helping prevent the harms of unnecessary treatment for indolent cancers.
Copyright © 2016 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Overdiagnosis; breast cancer; breast imaging; screening risks

Mesh:

Substances:

Year:  2016        PMID: 27017136      PMCID: PMC4867276          DOI: 10.1016/j.acra.2016.02.008

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  58 in total

1.  Changes in breast cancer therapy because of pathology second opinions.

Authors:  Valerie L Staradub; Kathleen A Messenger; Nanjiang Hao; Elizabeth L Wiley; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

Review 2.  Multiparametric magnetic resonance imaging of breast cancer.

Authors:  Michael A Jacobs
Journal:  J Am Coll Radiol       Date:  2009-07       Impact factor: 5.532

3.  Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.

Authors:  Sun-Ah Kim; Nariya Cho; Eun Bi Ryu; Mirinae Seo; Min Sun Bae; Jung Min Chang; Woo Kyung Moon
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

4.  Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Steven A Narod; Javaid Iqbal; Vasily Giannakeas; Victoria Sopik; Ping Sun
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

5.  Diagnostic concordance among pathologists interpreting breast biopsy specimens.

Authors:  Joann G Elmore; Gary M Longton; Patricia A Carney; Berta M Geller; Tracy Onega; Anna N A Tosteson; Heidi D Nelson; Margaret S Pepe; Kimberly H Allison; Stuart J Schnitt; Frances P O'Malley; Donald L Weaver
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

6.  Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.

Authors:  Elizabeth J Sutton; Jung Hun Oh; Brittany Z Dashevsky; Harini Veeraraghavan; Aditya P Apte; Sunitha B Thakur; Joseph O Deasy; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2015-04-07       Impact factor: 4.813

7.  Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

Authors:  Karla Kerlikowske; Annette M Molinaro; Mona L Gauthier; Hal K Berman; Fred Waldman; James Bennington; Henry Sanchez; Cynthia Jimenez; Kim Stewart; Karen Chew; Britt-Marie Ljung; Thea D Tlsty
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

Review 8.  Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.

Authors:  Shahla Masood
Journal:  Womens Health (Lond)       Date:  2012-01

Review 9.  Progression from ductal carcinoma in situ to invasive breast cancer: revisited.

Authors:  Catherine F Cowell; Britta Weigelt; Rita A Sakr; Charlotte K Y Ng; James Hicks; Tari A King; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2013-07-12       Impact factor: 6.603

Review 10.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Authors:  Beth A Virnig; Todd M Tuttle; Tatyana Shamliyan; Robert L Kane
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

View more
  12 in total

1.  The mammography debate: the senior years.

Authors:  C Kaniklidis
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

2.  Wherein the authors attempt to minimize the confusion generated by their study "Breast cancer mortality after a diagnosis of ductal carcinoma in situ" by several commentators who disagree with them and a few who don't: a qualitative study.

Authors:  S A Narod; H Ahmed; V Sopik
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

3.  Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance.

Authors:  Carlos Chavez de Paz Villanueva; Valentina Bonev; Maheswari Senthil; Naveenraj Solomon; Mark E Reeves; Carlos A Garberoglio; Jukes P Namm; Sharon S Lum
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

4.  Optimal Screening in Breast Cancer Survivors With Dense Breasts on Mammography.

Authors:  Habib Rahbar; Janie M Lee; Christoph I Lee
Journal:  J Clin Oncol       Date:  2020-07-24       Impact factor: 50.717

5.  Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.

Authors:  Jose-Gerardo Tamez-Peña; Juan-Andrés Rodriguez-Rojas; Hugo Gomez-Rueda; Jose-Maria Celaya-Padilla; Roxana-Alicia Rivera-Prieto; Rebeca Palacios-Corona; Margarita Garza-Montemayor; Servando Cardona-Huerta; Victor Treviño
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 6.  Radiomics in Breast Imaging from Techniques to Clinical Applications: A Review.

Authors:  Seung Hak Lee; Hyunjin Park; Eun Sook Ko
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

Review 7.  A New Challenge for Radiologists: Radiomics in Breast Cancer.

Authors:  Paola Crivelli; Roberta Eufrasia Ledda; Nicola Parascandolo; Alberto Fara; Daniela Soro; Maurizio Conti
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

8.  Additive Benefit of Radiomics Over Size Alone in the Distinction Between Benign Lesions and Luminal A Cancers on a Large Clinical Breast MRI Dataset.

Authors:  Heather M Whitney; Nathan S Taylor; Karen Drukker; Alexandra V Edwards; John Papaioannou; David Schacht; Maryellen L Giger
Journal:  Acad Radiol       Date:  2018-05-10       Impact factor: 5.482

Review 9.  Precision Medicine for Breast Cancer: The Paths to Truly Individualized Diagnosis and Treatment.

Authors:  Eleanor E R Harris
Journal:  Int J Breast Cancer       Date:  2018-05-09

10.  Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Authors:  Gregory Penzias; Asha Singanamalli; Robin Elliott; Jay Gollamudi; Natalie Shih; Michael Feldman; Phillip D Stricker; Warick Delprado; Sarita Tiwari; Maret Böhm; Anne-Maree Haynes; Lee Ponsky; Pingfu Fu; Pallavi Tiwari; Satish Viswanath; Anant Madabhushi
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.